Therapeutic Erythrocytapheresis in the Initial Treatment of Hereditary Hemochromatosis
Background: The current treatment of hereditary hemochromatosis (HH) consists of performing periodic whole blood phlebotomies. Erythrocytapheresis (EA) can remove up to three times more red blood cells per single procedure and could thus have a clinical benefit. A prospective study of 30 consecutive...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2012-01-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | https://actamedica.lfhk.cuni.cz/55/4/0180/ |